Balance: A Pragmatic Trial of a Digital Health Intervention to Prevent Weight Gain in Primary Care

Sponsor
Duke University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03003403
Collaborator
(none)
443
1
2
75.9
5.8

Study Details

Study Description

Brief Summary

Up to 50% of obese patients are not interested in, or ready for, weight loss. Clinical practice guidelines clearly recommend that these patients avoid gaining weight. However, despite this clinical guideline, weight gain prevention interventions are not available in primary care practice. Balance is a pragmatic, randomized controlled effectiveness trial for weight gain prevention for patients within rural community health centers, using a digital health platform.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Intervention Program
N/A

Detailed Description

Clinical practice guidelines emphasize recommend weight gain prevention, but evidence-based treatments are not available in primary care. Balance, a pragmatic effectiveness trial, will test a scalable treatment approach for medically-vulnerable adults, those who suffer disproportionately from obesity and its adverse health effects. Balance builds on the design and findings of the Shape study (NCT00938535) to test a pragmatic intervention within rural community health centers. Balance will randomize overweight adults and adults with obesity who are patients a local community health center network (Piedmont Health Services) to either: 1) a 12-month weight gain prevention intervention or 2) usual care. Intervention group components include tailored behavior change goals; mHealth self-monitoring and feedback; skills training videos; and stepped responsive coaching from clinic Registered Dietitians. The usual care group will receive standard primary care offered by their providers and automated text messages and health information about maintaining a healthy weight. All intervention components and materials will be provided in Spanish or English.

Study Design

Study Type:
Interventional
Actual Enrollment :
443 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Balance: A Pragmatic Trial of a Digital Health Intervention to Prevent Weight Gain in Primary Care
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Apr 30, 2022
Anticipated Study Completion Date :
Apr 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Program

Balance Intervention Program: Participants randomly assigned to the 12-month digital health behavioral intervention will receive: tailored behavior change goals with interactive self-monitoring and feedback; network-connected scales to track their weight; skills training materials; and stepped coaching (via phone and/or text) from Registered Dieticians serving as health coaches within a local network of community health centers.

Behavioral: Intervention Program
Balance is testing a pragmatic approach to promote weight maintenance among overweight patients and patients with obesity within local community health centers who experience barriers to losing weight. The intervention utilizes the interactive obesity treatment approach, which creates an energy deficit by having participants achieve simple, straightforward, and concrete behavior change goals (e.g., no fast food, no sugary drinks, walk 10,000 steps per day). The Balance intervention involves tailored behavior change goals; self-monitoring using connected scales and mobile technologies; responsive coaching, and tailored feedback and skills training.

No Intervention: Usual Care Program

Balance Usual Care Program: Participants randomly assigned to the Usual Care program will receive the standard primary care offered by their providers; health information/skills training materials to maintain a healthy weight; and automated (non-tailored) text messages with health information.

Outcome Measures

Primary Outcome Measures

  1. Change in weight [baseline, 24 months post-randomization (up to 27 months to obtain 24 month data)]

    The proportion of intervention arm participants who achieve weight maintenance (staying within 3% of baseline weight in kg) at 24 months post-randomization. This will be calculated as follows: ((baseline weight in kg - final weight at 24 months in kg)/baseline weight in kg))x 100

Secondary Outcome Measures

  1. Change in blood pressure [baseline, 24 months post-randomization (up to 27 months to obtain 24 month data)]

    Average change in participant systolic and diastolic blood pressure at 24 months post-randomization, as measured in millimeters of mercury (mm Hg)

  2. Change in Framingham risk score [baseline, 24 months post-randomization (up to 27 months to obtain 24 month data)]

    Average change in participant Framingham risk score at 24 months post-randomization, as measured by calculated 10-year Framingham risk score from the Framingham Heart Study

  3. Intervention cost-effectiveness [24 months post-randomization (up to 27 months to obtain 24 month data)]

    Assess the intervention's incremental cost at 24 months post-randomization, defined as the cost-effectiveness ratio of cost in dollars per kg of weight maintained at 24 mos, as compared to baseline weight in kg.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients of Piedmont Health Services' community health centers in central North Carolina only

  • BMI between 25 and 40 kg/m2 and weighs less than 380 lbs

  • Speaks English or Spanish

  • Had a non-urgent outpatient visit at a participating community health center clinic at Piedmont Health Services within the last 2 weeks

  • Has a cell phone

  • Willing to receive 3-12 study-related text messages per week

Exclusion Criteria:
  • Current Piedmont Health Services employee

  • Has past bariatric surgery or planned bariatric surgery (within next 2 years)

  • Diagnosed with cancer in the last 6 months and is in active treatment

  • Has a history of cardiovascular event (stroke/MI) in the last 12 months

  • Was hospitalized for a mental health issue in the last 12 months

  • Diagnosis of end stage renal disease

  • Currently participating in a weight loss program/research study

  • Plans to move out of area and not receive care within community health center network (within the next 2 years)

  • Currently or recently pregnant (within the last 6 months) - Females only

  • Currently or recently lactating (with the last 2 months)- Females only

  • Plans to get pregnant in the next 12 months - Females only

Contacts and Locations

Locations

Site City State Country Postal Code
1 Duke University - with Piedmont Health Services, Inc. Durham North Carolina United States 27708

Sponsors and Collaborators

  • Duke University

Investigators

  • Principal Investigator: Gary G Bennett, PhD, Duke University
  • Principal Investigator: Dori M Steinberg, PhD, RD, Duke University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT03003403
Other Study ID Numbers:
  • D0479
First Posted:
Dec 28, 2016
Last Update Posted:
Jul 26, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Duke University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 26, 2022